Indraprastha Medical Corporation Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2025. Further, the company has informed the Exchange regarding voting results.
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indraprastha Medical Corporation (Indraprastha Apollo Hospitals) held its 37th AGM on September 24, 2025, via video conferencing, where all seven resolutions were passed. Shareholders approved the FY25 financial statements, the re-appointment of Dr. Suneeta Reddy and Dr. Sangita Reddy (both retiring by rotation), and a dividend of Rs. 4.50 per equity share (45% on face value of Rs. 10). They also approved the appointment of Mr. Sudhir Jalan as an Independent Director for five years and M/s RSM & Co. as Secretarial Auditors for five years, along with ratification of Cost Auditors' remuneration for FY26. Of 81,682 shareholders on record date (September 18, 2025), about 27.65 million shares (~30.16% of total equity) were polled. Most resolutions received near-unanimous support (over 99% in favour), while the appointments of the new Independent Director (91.28% in favour) and RSM & Co. as Secretarial Auditor (91.32% in favour) saw some institutional dissent but still passed comfortably.
Shareholders are set to receive a Rs. 4.50 per share dividend. The clean passage of all resolutions signals stable governance and continued promoter control, though the relatively lower ~91% approval on the new Independent Director and secretarial auditor appointments reflects some pushback from public institutional investors that retail shareholders can monitor.